
    
      In Neo-adjuvant period Four cycles of 60 mg/m2 doxorubicin and 600 mg/m2 cyclophosphamide
      therapy at 3-week intervals followed by four cycles of 100 mg/m2 docetaxel at 3-week
      intervals.

      In POST Neo-adjuvant period

      Randomization:

      At the time of post neo-adjuvant period, the patients will be assigned to each treatment
      group in a 1:1 ratio i.e. carboplatin AUC 6 group vs. observation group. Six cycles of
      carboplatin (AUC=6) on the first day of every 21 days.
    
  